Health product recall

Baxter Corporation; leaks of intravenous bags

Last updated

Summary

Product
0.9% SODIUM CHLORIDE INJECTION & LACTATED RINGER'S INJECTION
Issue
Health products - Product quality
What to do

Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.

Affected products

Brand

Product Name

Market Authorization

Dosage Form

Strength

Lot number

BAXTER CORPORATION

0.9% SODIUM CHLORIDE INJECTION, USP

DIN 00060208

Solution

SODIUM CHLORIDE 900mg / 100mL

W1I14B0F, W1I15B0, W1I23B0, W1I24B0, W1I30B0, W1J07B0, W1J20B0, W1J22B0, W1J25B1, W1J26B0, W1J27B1, W1J29B0, W1K02B0, W1K03B0, W1K19B0, W1K25B0, W1K25B0F, W1L02B0, W1L03B0, W1L09B0, W1L10B0, W1L10B0B, W1L11B0, W1L16B0, W1L17B0, W2A13B0, W2A14B0, W2A19B1, W2A20B0, W2A21B0, W2A22B0, W2A26B0, W2A29B0, W1H13B0, W1H19B0, W1H20B0, W1H26B0, W1H27B0, W1I01B0, W1I03B0, W1I09B0, W1I10B0, W1I14B0

BAXTER CORPORATION

LACTATED RINGER'S INJECTION, USP

DIN 00061085

Solution

CALCIUM CHLORIDE 20mg / 100mL; POTASSIUM CHLORIDE 30mg / 100mL; SODIUM CHLORIDE 600mg / 100 mL; SODIUM LACTATE 310mg / 100mL

W1H04B0, W1I17B0, W1J28B0, W1K26B0, W1L22B0, W2A27B0, W2A27B0S

Issue

Intravenous bag may be leaking in affected lots.

What you should do

  1. Verify if your product is affected.
  2. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
  3. Contact the recalling firm if you have any questions about the recall.
  4. Report any health product related side effects to Health Canada.
  5. Report any other health product safety complaints to Health Canada.

Additional information

Background

Depth of recall: End Users

Details
Original published date: 2022-11-03
Alert / recall type
Health product recall
Category
Health product
Companies

Baxter Corporation

7125 Mississauga Road

Mississauga ON

L5N 0C2

Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type I
Identification number
RA-72165